Ligand validation:4OO9

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4OO9_MES_A_4006	67%	9%	0.17	0.978	2.63	1.84	1	3	0	0	100%	1
6FFI_MES_A_4006	71%	9%	0.144	0.965	2.6	1.95	1	3	0	0	100%	1
5CGC_MES_A_4005	48%	10%	0.212	0.955	2.68	1.72	1	3	1	0	100%	1
6FFH_MES_A_4005	32%	10%	0.235	0.91	2.3	2.05	1	6	0	0	100%	1
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
9K7M_MES_A_401	100%	67%	0.022	0.998	0.69	0.57	-	-	0	0	100%	1
5TNY_MES_A_501	100%	10%	0.03	0.994	1.72	2.64	1	6	0	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.